v3.23.1
Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Total
IPO
Series C Convertible Preferred Stock
Convertible Preferred Stock
Preferred Stock
Series A Convertible Preferred Stock
Preferred Stock
Series B Convertible Preferred Stock
Preferred Stock
Series C Convertible Preferred Stock
Preferred Stock
Series A and B Convertible Preferred Stock
Preferred Stock
Convertible Preferred Stock
Common Stock
Common Stock
IPO
Common Stock
Series A Convertible Preferred Stock
Common Stock
Series C Convertible Preferred Stock
Common Stock
Series A and B Convertible Preferred Stock
Additional Paid-in Capital
Additional Paid-in Capital
IPO
Additional Paid-in Capital
Series C Convertible Preferred Stock
Additional Paid-in Capital
Series A and B Convertible Preferred Stock
Accumulated Deficit
$1.5M Notes
$1.5M Notes
Common Stock
$1.5M Notes
Additional Paid-in Capital
Bridge Notes and Accrued Interest
Bridge Notes and Accrued Interest
Common Stock
Bridge Notes and Accrued Interest
Additional Paid-in Capital
Beginning Balance, Shares at Apr. 30, 2020         10,000 10,000 455,265     3,313,841                              
Beginning Balance at Apr. 30, 2020 $ 315,551       $ 10 $ 10 $ 455   $ 475 $ 3,313         $ 47,434,241       $ (47,122,478)            
Sale of Common Stock and warrants, net of fees, Shares     8,000             0                              
Sale of Common Stock and warrants, net of fees     $ 200,000                                            
Stock based compensation – management & other employees 16,929                           16,929                    
Warrants issued to non-employees 2,354                           2,354                    
Net loss (2,452,170)                                   (2,452,170)            
Ending Balance, Shares at Apr. 30, 2021         10,000 10,000 463,265     3,313,841                              
Ending Balance at Apr. 30, 2021 (1,909,590)       $ 10 $ 10 $ 463   $ 483 $ 3,313         47,661,262       (49,574,648)            
Stock based compensation—non-employee advisers 7,746                           7,746                    
Series C convertible preferred stock issued to investors 200,000           $ 8               199,992                    
Series C convertible preferred stock issued to investors ,shares             8,000   8                                
Common Stock issued to non-employees,shares                   10,101                              
Common Stock issued to non-employees 35,000                 $ 10         34,990                    
Stock based compensation – management & other employees 83,250                           83,250                    
Warrants issued to non-employees 464,667                           464,667                    
Net loss (2,775,124)                                   (2,775,124)            
Ending Balance, Shares at Jan. 31, 2022         10,000 10,000 463,265     3,323,942                              
Ending Balance at Jan. 31, 2022 (4,101,797)       $ 10 $ 10 $ 463   $ 483 $ 3,323         48,244,169       (52,349,772)            
Beginning Balance, Shares at Apr. 30, 2021         10,000 10,000 463,265     3,313,841                              
Beginning Balance at Apr. 30, 2021 (1,909,590)       $ 10 $ 10 $ 463   483 $ 3,313         47,661,262       (49,574,648)            
Sale of Common Stock and warrants, net of fees, Shares       0                                          
Common Stock issued upon conversion, Shares                   703,290                              
Common Stock issued to non-employees,shares                   10,101                              
Common Stock issued to non-employees 35,000                 $ 10         34,990                    
Stock based compensation – management & other employees 68,396                           68,396                    
Warrants issued to non-employees 578,657                           578,657                    
Net loss (4,828,260)                                   (4,828,260)            
Ending Balance, Shares at Apr. 30, 2022         10,000 10,000 463,265     3,323,942                              
Ending Balance at Apr. 30, 2022 (6,055,797)       $ 10 $ 10 $ 463   483 $ 3,323         48,343,305       (54,402,908)            
Beginning Balance, Shares at Oct. 31, 2021         10,000 10,000 463,265     3,313,841                              
Beginning Balance at Oct. 31, 2021 (3,442,185)       $ 10 $ 10 $ 463   483 $ 3,313         47,665,288       (51,111,269)            
Common Stock issued to non-employees,shares                   10,101                              
Common Stock issued to non-employees 35,000                 $ 10         34,990                    
Stock based compensation – management & other employees 80,833                           80,833                    
Warrants issued to non-employees 463,058                           463,058                    
Net loss (1,238,503)                                   (1,238,503)            
Ending Balance, Shares at Jan. 31, 2022         10,000 10,000 463,265     3,323,942                              
Ending Balance at Jan. 31, 2022 (4,101,797)       $ 10 $ 10 $ 463   483 $ 3,323         48,244,169       (52,349,772)            
Beginning Balance, Shares at Apr. 30, 2022         10,000 10,000 463,265     3,323,942                              
Beginning Balance at Apr. 30, 2022 $ (6,055,797)       $ 10 $ 10 $ 463   483 $ 3,323         48,343,305       (54,402,908)            
Sale of Common Stock and warrants, net of fees, Shares 5,025,917                 5,025,917 1,500,000                            
Sale of Common Stock and warrants, net of fees   $ 5,194,740                 $ 1,500         $ 5,193,240                  
Common Stock issued upon conversion, Shares     60,037   (10,000) (10,000) (60,037)     230,086   703,290 230,086 703,290             909,071     1,544,114  
Common Stock issued upon conversion of convertible preferred stock         $ (10) $ (10) $ (60) $ (20)         $ 231 $ 703     $ (171) $ (683)   $ 1,500,000 $ 909 $ 1,499,091 $ 3,618,704 $ 1,544 $ 3,617,160
Common Stock issued upon exercise of pre-funded warrants,share                   139,356                              
Common Stock issued upon exercise of pre-funded warrants $ 14                 $ 139         (125)                    
Stock based compensation – management & other employees 149,153                           149,153                    
Warrants issued to non-employees 57,203                           57,203                    
Net loss (4,721,929)                                   (4,721,929)            
Ending Balance, Shares at Jan. 31, 2023         0 0 403,228     8,349,859                              
Ending Balance at Jan. 31, 2023 (257,912)       $ 0 $ 0 $ 403   403 $ 8,349         58,858,173       (59,124,837)            
Beginning Balance, Shares at Oct. 31, 2022             403,228     8,210,503                              
Beginning Balance at Oct. 31, 2022 1,082,676           $ 403   403 $ 8,210         58,856,785       (57,782,722)            
Common Stock issued upon exercise of pre-funded warrants,share                   139,356                              
Common Stock issued upon exercise of pre-funded warrants 14                 $ 139         (125)                    
Stock based compensation – management & other employees 1,513                           1,513                    
Net loss (1,342,115)                                   (1,342,115)            
Ending Balance, Shares at Jan. 31, 2023         0 0 403,228     8,349,859                              
Ending Balance at Jan. 31, 2023 $ (257,912)       $ 0 $ 0 $ 403   $ 403 $ 8,349         $ 58,858,173       $ (59,124,837)